Business and Finance Business and Finance
Fri, July 31, 2009
Thu, July 30, 2009
Wed, July 29, 2009
Tue, July 28, 2009
Mon, July 27, 2009
Sun, July 26, 2009
Fri, July 24, 2009
Thu, July 23, 2009
Wed, July 22, 2009
Tue, July 21, 2009
Mon, July 20, 2009
Fri, July 17, 2009
Thu, July 16, 2009
Wed, July 15, 2009

Innovotech Inc.: Innovotech Inc.: Media Advisory- A Breakthrough in the Treatment of Serious Infections


Published on 2009-07-24 08:57:22, Last Modified on 2009-07-24 08:57:31 - Market Wire
  Print publication without navigation


EDMONTON, ALBERTA--(Marketwire - July 24, 2009) - Innovotech (TSX VENTURE:IOT) - Media are invited to a press conference announcing a clinically-proven test of immense interest to the medical community and people everywhere dealing with chronic infections that are potentially life threatening.

The benefits of this test include reducing the incidents of resistance to antibiotics and savings to the health care system. It has received regulatory approval by Health Canada and has met all current standards of the Clinical Laboratory Standards Institute (CLSI) for reproducibility and consistency.

Press conference details:

When: Tuesday, July 28, 2009 - 10 a.m.

Where: 203 Advanced Technology Centre in Edmonton Research Park, 9650 20 Avenue NW

Available for interviews will be the two doctors who led the clinical research as well as one of the patients in the study and the CEO of Innovotech. A tour of the lab where the test was developed will be conducted following the press conference. A DVD of stock footage and interview clips is available upon request.

Toronto-based media please note that a further clinical evaluation of this test is now underway at the Hospital for Sick Children and St. Michael's Hospital. The doctor leading the evaluation at St.Michael's Hospital is also available for interviews.



Publication Contributing Sources

Similar Business and Finance Publications